Jump to content

ACR score

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 21:55, 9 August 2022 (Add: pmid, issue. | Use this bot. Report bugs. | Suggested by Abductive | #UCB_webform 2802/3849). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ACR score
PurposeQuantify degree of symptoms in rheumatoid arthritis[1]

ACR score is a scale to measure change in rheumatoid arthritis symptoms.[1] It is named after the American College of Rheumatology. The ACR score is more often used in clinical trials than in doctor patient-relationships, as it allows a common standard between researchers.

Different degrees of improvement are referred to as ACR20, ACR50, ACR70. ACR20 was initially proposed with ACR scoring, measuring a 20% improvement on a scale of 28 intervals. ACR50 and ACR70 were later proposed, corresponding to 50% and 70% improvements.[2]

The Rheumatoid Arthritis Severity Scale (RASS) is based on sections of the ACR scoring system.[3]

The 2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria, which includes anti-CCP testing, has been developed to focus on early disease, and on features that are associated with persistent or erosive disease.[4]

References

  1. ^ a b Felson at al. (1995). "ACR Preliminary Definition of Improvement in Rheumatoid Arthritis". {{cite journal}}: Cite journal requires |journal= (help)
  2. ^ Rocha, Kathleen. "ACR Score: Measuring Rheumatoid Arthritis". RheumatoidArthritis.org. Retrieved 4 April 2017.
  3. ^ Bardwell; et al. (2002). "Rheumatoid Arthritis Severity Scale: a brief, physician-completed scale not confounded by patient self-report of psychological functioning". Rheumatology. 41 (1): 38–45. doi:10.1093/rheumatology/41.1.38. PMID 11792878.
  4. ^ Aletaha D, Neogi T, Silman AJ, et al. (September 2010). "2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative" (PDF). Ann. Rheum. Dis. 69 (9): 1580–8. doi:10.1136/ard.2010.138461. PMID 20699241.